Related references
Note: Only part of the references are listed.Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds
Monday O. Ogese et al.
TOXICOLOGICAL SCIENCES (2020)
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation
James C. Waddington et al.
TOXICOLOGICAL SCIENCES (2020)
Altered Expression and Function of Hepatic Transporters in a Rodent Model of Polycystic Kidney Disease
Jacqueline Bezencon et al.
DRUG METABOLISM AND DISPOSITION (2019)
Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01
Qing Zhao et al.
ALLERGY (2019)
miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model
Merrie Mosedale et al.
TOXICOLOGICAL SCIENCES (2018)
Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy
M. E. Azoury et al.
ALLERGY (2018)
β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells
Andrew Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
Jeffrey L. Woodhead et al.
TOXICOLOGICAL SCIENCES (2017)
Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients
Xiaoli Meng et al.
JOURNAL OF IMMUNOLOGY (2017)
Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis
Monica Mazzarino et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity
Lee Faulkner et al.
TOXICOLOGICAL SCIENCES (2016)
Mechanisms of tolvaptan-induced toxicity in HepG2 cells
Yuanfeng Wu et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
Paul B. Watkins et al.
DRUG SAFETY (2015)
Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury
Seung-Hyun Kim et al.
HEPATOLOGY (2015)
T-Cells from HLA-B*57:01+ Human Subjects Are Activated with Abacavir through Two Independent Pathways and Induce Cell Death by Multiple Mechanisms
Catherine C. Bell et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Human Leukocyte Antigen (HLA)-B☆57:01-Restricted Activation of Drug-Specific T Cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury
Manal M. Monshi et al.
HEPATOLOGY (2013)
HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity
Benno Schnyder et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Role of interstitial inflammation in the pathogenesis of polycystic kidney disease
Michelle H. T. Ta et al.
NEPHROLOGY (2013)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
Avidity determines T-cell reactivity in abacavir hypersensitivity
Jacqueline Adam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Patricia T. Illing et al.
NATURE (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Development of In Vitro Culture Methods to Characterize Primary T-Cell Responses to Drugs
Lee Faulkner et al.
TOXICOLOGICAL SCIENCES (2012)
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
M. Isabel Lucena et al.
GASTROENTEROLOGY (2011)
Mass Spectrometric Characterization of Circulating and Functional Antigens Derived from Piperacillin in Patients with Cystic Fibrosis
Paul Whitaker et al.
JOURNAL OF IMMUNOLOGY (2011)
Stimulation of human T cells with sulfonamides and sulfonamide metabolites
J. Luis Castrejon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
Generation and characterization of antigen-specific CD4(+), CD8(+), and CD4(+)CD8(+) T-cell clones from patients with carbamazopine hypersensitivity
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Activation of T cells by carbamazepine and carbamazepine metabolites
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Tolvaptan.: Treatment of heart failure, vasopressin V2 antagonist.
LA Sorbera et al.
DRUGS OF THE FUTURE (2002)
Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals
B Schnyder et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
